These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9592636)

  • 21. [Lipoprotein(a) concentrations in type I diabetes mellitus].
    Figueroa AC; Gil RL; Pedragós AC; González GC; Marqués RB; Díaz JA; Llanos JO; Pérez AP
    Rev Clin Esp; 1996 Feb; 196(2):87-91. PubMed ID: 8685494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyses of serum lipoprotein(a) and the relation to phenotypes and genotypes of apolipoprotein(a) in type 2 diabetic patients with retinopathy.
    Suehiro M; Ohkubo K; Kato H; Kido Y; Anzai K; Oshima K; Ono J
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):319-24. PubMed ID: 12397529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein (a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in South India.
    Rajappa M; Sridhar MG; Balachander J; Sethuraman KR
    Clin Chim Acta; 2006 Oct; 372(1-2):70-5. PubMed ID: 16701602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients.
    Testa R; Bonfigli AR; Sirolla C; Pieri C; Marra M; Antonicelli R; Manfrini S; Compagnucci P; Testa I
    Diabetes Nutr Metab; 1999 Dec; 12(6):400-6. PubMed ID: 10782561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
    Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
    Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones.
    Varo N; Vicent D; Libby P; Nuzzo R; Calle-Pascual AL; Bernal MR; Fernández-Cruz A; Veves A; Jarolim P; Varo JJ; Goldfine A; Horton E; Schönbeck U
    Circulation; 2003 Jun; 107(21):2664-9. PubMed ID: 12742991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
    Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Uruski P; Wierusz-Wysocka B
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of oral hypoglycemic agents in therapy and prevention of macrovascular complications.
    Krall LP
    Horm Metab Res Suppl; 1985; 15():98-101. PubMed ID: 3908284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
    Wollesen F; Dahlén G; Berglund L; Berne C
    Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein(a) concentration in diabetes: relationship to proteinuria and diabetes control.
    Irish AB; Simons LA; Simons J
    Aust N Z J Med; 1992 Aug; 22(4):329-33. PubMed ID: 1445019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
    Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum 1,25-dihydroxyvitamin D in insulin-dependent diabetes mellitus].
    Muñoz-Torres M; de Madrid JD; Escobar-Jiménez F; Ortego Centeno N
    Med Clin (Barc); 1990 Jul; 95(6):207-9. PubMed ID: 2250544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipoprotein(a) in patients with diabetes mellitus.
    Heller FR; Jamart J; Honore P; Derue G; Novik V; Galanti L; Parfonry A; Hondekijn JC; Buysschaert M
    Diabetes Care; 1993 May; 16(5):819-23. PubMed ID: 8495624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Some parameters of hemostasis in diabetic patients].
    Sroczyński J; Krupa G; Chełmecka E; Galwas B; Matyszczyk B
    Pol Tyg Lek; 1989 May 1-8; 44(18-19):420-2. PubMed ID: 2700093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
    Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
    Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipoprotein(a) in diabetes mellitus.
    Ritter MM; Loscar M; Richter WO; Schwandt P
    Clin Chim Acta; 1993 Jan; 214(1):45-54. PubMed ID: 8453777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disordered Na+/H+ metabolism in the erythrocytes of patients with insulin-dependent diabetes mellitus].
    Balashova TS; Tomilova EN; Golega EN; Balabolkin MI; Kubatiev AA
    Ter Arkh; 1996; 68(2):53-6. PubMed ID: 8771660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic osteopenia in central Japan.
    Seino Y; Ishida H; Imura H; Akazawa Y; Aochi O; Hamada S; Horiuchi N; Hoshi M; Ikeda M; Igarashi T
    Diabete Metab; 1985 Aug; 11(4):216-9. PubMed ID: 3899764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between the stage of diabetic nephropathy and serum lipoprotein (a) concentrations--influence of hypoproteinemia].
    Nakagawa H; Kida Y; Sakamoto K; Haneda M; Kikkawa R
    Nihon Jinzo Gakkai Shi; 1996 Nov; 38(11):513-8. PubMed ID: 8958706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.